Trials / NCT02548572
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study
Withdrawn N/A Electrical stimulation
Why it stopped: Could not recruit patients
- Sponsor
- Wills Eye
- Treatment
- Transcorneal Electrical Stimulation using Okustim device
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 22 Years to 80 Years
- Enrollment
- Not stated participants
- Started
- 2019-01
- Main results expected
- 2020-12
- Results posted
- Not yet
- Record last updated
- 2019-05-01
What the study is testing
Several studies have shown that TES in RP patients may help to slow the progressive deterioration of this degenerative disease. The end point of this clinical trial is to slow or stop disease progression with weekly treatment using TES for 1 year.
Where it runs
United States (1)
- Wills Eye Health System, Philadelphia, Pennsylvania